Increased Risk of Hemorrhagic Transformation in Ischemic Stroke Occurring During Warfarin Anticoagulation: An Experimental Study in Mice

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Stroke

• Publication date

  2011-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/STROKEAHA.110.604652PMID 21330626
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Relation of effective anticoagulation in patients with atrial fibrillation to stroke severity and survival (from the National Acute Stroke Israeli Survey [NASIS]).

  2010cited by this paper
• Effect of clopidogrel added to aspirin in patients with atrial fibrillation.

  2009cited by this paper
• The immunomodulatory sphingosine 1-phosphate analog FTY720 reduces lesion size and improves neurological outcome in a mouse model of cerebral ischemia.

  2009cited by this paper
• Rapid Reversal of Anticoagulation Reduces Hemorrhage Volume in a Mouse Model of Warfarin-Associated Intracerebral Hemorrhage

  2009cited by this paper
• Dabigatran versus warfarin in patients with atrial fibrillation.

  2009cited by this paper
• Experimental Model of Warfarin-Associated Intracerebral Hemorrhage

  2008cited by this paper
• Prothrombin complex concentrate (Beriplex® P/N) for emergency anticoagulation reversal: a prospective multinational clinical trial

  2008cited by this paper
• Guidelines for the Early Management of Adults With Ischemic Stroke

  2007cited by this paper
• Trends in anticoagulation for atrial fibrillation in the U.S.: an analysis of the national ambulatory medical care survey database.

  2007cited by this paper
• Efficacy and Safety of Anticoagulant Treatment in Acute Cardioembolic Stroke: A Meta-Analysis of Randomized Controlled Trials

  2007cited by this paper
• Preadmission antithrombotic treatment and stroke severity in patients with atrial fibrillation and acute ischaemic stroke: an observational study.

  2006cited by this paper
• Frequency and effect of optimal anticoagulation before onset of ischaemic stroke in patients with known atrial fibrillation

  2005cited by this paper
• The epidemiology of atrial fibrillation in elderly persons: the tip of the iceberg.

  2005cited by this paper
• Evidence of Reperfusion Injury, Exacerbated by Thrombolytic Therapy, in Human Focal Brain Ischemia Using a Novel Imaging Marker of Early Blood–Brain Barrier Disruption

  2004cited by this paper
• Matrix Metalloproteinase-9 Pretreatment Level Predicts Intracranial Hemorrhagic Complications After Thrombolysis in Human Stroke

  2003cited by this paper
• Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation.

  2003cited by this paper
• Rapid reversal of oral anticoagulation with warfarin by a prothrombin complex concentrate (Beriplex): efficacy and safety in 42 patients

  2002cited by this paper
• Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.

  2001cited by this paper
• Classification and natural history of clinically identifiable subtypes of cerebral infarction.

  1991cited by this paper

• Intracranial hemorrhage after ischemic stroke in patients on direct oral anticoagulants: results from a prospective observational study

  2026cites this paper
• Prior Anticoagulation and Risk of Hemorrhagic Transformation in Acute Stroke: A Post Hoc Analysis of the PRODAST Study

  2025cites this paper
• Intravenous thrombolysis in patients with recent intake of direct oral anticoagulants: A target trial analysis after the liberalization of institutional guidelines

  2024cites this paper
• Intravenous thrombolysis and mechanical thrombectomy in acute stroke patients on direct oral anticoagulants

  2024cites this paper
• Assessing mortality and safety of IV thrombolysis in ischemic stroke patients on direct oral anticoagulants (DOACs): A systematic review and meta-analysis.

  2024cites this paper
• Thrombolysis for Ischemic Stroke Despite Recent Ingestion of Direct Oral Anticoagulants – A Growing Dilemma Also in India

  2024cites this paper
• Meta-analysis of outcomes following intravenous thrombolysis in patients with ischemic stroke on direct oral anticoagulants

  2023cites this paper
• Intravenous Thrombolysis in Patients With Ischemic Stroke and Recent Ingestion of Direct Oral Anticoagulants

  2023cites this paper
• Why Does It Shine?—A Prognostic Analysis about Predisposing Factors for Blood–Brain Barrier Damage after Revascularisation of Cerebral Large-Vessel Occlusion

  2023cites this paper
• Effect of INR on Outcomes of Endovascular Treatment for Acute Vertebrobasilar Artery Occlusion

  2023cites this paper
• Cardioembolic stroke with hemorrhagic transformation in atrial fibrillation patients on anticoagulant therapy: A case report

  2023cites this paper
• Prognostic significance of international normalised ratio and prothrombin time in Chinese acute ischaemic stroke patients

  2022cites this paper
• Anticoagulation Resumption After Stroke from Atrial Fibrillation

  2019cites this paper
• Contributions of 12/15-Lipoxygenase to Bleeding in the Brain Following Ischemic Stroke.

  2019cites this paper
• Animal Models of Focal Cerebral Ischaemia and Haemorrhagic Transformation: Considerations in Experimental Stroke Study Design.

  2018cites this paper
• Thrombolysis with rt-PA under Rivaroxaban Anticoagulation in a Hypertensive Rat Model of Intraluminal Middle Cerebral Artery Occlusion.

  2018cites this paper
• Recurrent Hemorrhagic Conversion of Ischemic Stroke in a Patient with Mechanical Heart Valve: A Case Report and Literature Review

  2018cites this paper
• Beneficial Role of Rosuvastatin in Blood–Brain Barrier Damage Following Experimental Ischemic Stroke

  2018cites this paper
• Direkte orale Antikoagulanzien und akuter Schlaganfall

  2017cites this paper
• Anticoagulants inhibit proteolytic clearance of plasma amyloid beta

  2017cites this paper
• Risk of long-term anticoagulation under sustained severe arterial hypertension: A translational study comparing warfarin and the new oral anticoagulant apixaban

  2017cites this paper
• 12/15-Lipoxygenase Inhibition or Knockout Reduces Warfarin-Associated Hemorrhagic Transformation After Experimental Stroke

  2017cites this paper
• Haemorrhagic Transformation after Ischaemic Stroke in Patients Taking Non-vitamin K Antagonist Oral Anticoagulants

  2017cites this paper
• Management of acute stroke in patients on oral anticoagulants

  2017cites this paper
• Pharmacological Management Options to Prevent and Reduce Ischemic Hemorrhagic Transformation.

  2017cites this paper
• The cerebral circulation and cerebrovascular disease III: Stroke

  2017cites this paper
• [Direct oral anticoagulants and acute stroke : Insights into translational research studies].

  2017cites this paper
• Systematic review of survival time in experimental mouse stroke with impact on reliability of infarct estimation.

  2016cites this paper
• Estimating the Quantitative Demand of NOAC Antidote Doses on Stroke Units

  2016cites this paper
• Non-vitamin K antagonist anticoagulants to cardio embolic ischemic stroke due to atrial fibrillation: a brief update to clinical practice

  2016cites this paper
• The glucagon-like peptide-1 receptor agonist exendin-4 ameliorates warfarin-associated hemorrhagic transformation after cerebral ischemia

  2016cites this paper
• Nrf2 activator ameliorates hemorrhagic transformation in focal cerebral ischemia under warfarin anticoagulation.

  2016influential citation
• Estimating the Quantitative Demand of NOAC Antidote Doses on Stroke Units.

  2016cites this paper
• Liver function may play an uneven role in haemorrhagic transformation for stroke subtypes after acute ischaemic stroke

  2016cites this paper
• Acute management of stroke patients taking non-vitamin K antagonist oral anticoagulants Addressing Real-world Anticoagulant Management Issues in Stroke (ARAMIS) Registry: Design and rationale.

  2016cites this paper
• Blocking of plasma kallikrein ameliorates stroke by reducing thromboinflammation

  2015cites this paper
• Treatment Preferences and Prognosis of Acute Traumatic Brain Injury; Outcomes in the Patients who were on Antiplatelet Therapy

  2015cites this paper
• Hemorrhagic Transformation after Tissue Plasminogen Activator Reperfusion Therapy for Ischemic Stroke: Mechanisms, Models, and Biomarkers

  2014cites this paper
• Hemorrhagic transformation after cerebral infarction: current concepts and challenges.

  2014cites this paper
• Sulfonylharnstoffe und ihr Einfluss auf eine hämorrhagische Transformation bei Patienten nach akutem Schlaganfall

  2014cites this paper
• Hemorrhagic Transformation after Ischemic Stroke in Animals and Humans

  2014cites this paper
• SMTP-7, a new thrombolytic agent, decreases hemorrhagic transformation after transient middle cerebral artery occlusion under warfarin anticoagulation in mice.

  2014cites this paper
• Translational Insights into Traumatic Brain Injury Occurring during Dabigatran or Warfarin Anticoagulation

  2014cites this paper
• Prognostic factors of functional outcome in acute ischemic stroke

  2013cites this paper
• Coadministration of FTY720 and rt-PA in an experimental model of large hemispheric stroke–no influence on functional outcome and blood–brain barrier disruption

  2013cites this paper
• Treatment of acute ischaemic stroke with thrombolysis or thrombectomy in patients receiving anti-thrombotic treatment.

  2013cites this paper
• Cilostazol Ameliorates Warfarin-Induced Hemorrhagic Transformation After Cerebral Ischemia in Mice

  2013cites this paper
• Caracterización biológica y clínica del riesgo trombótico y hemorrágico de pacientes con fibrilación auricular no valvular bajo tratamiento anticoagulante oral.

  2013cites this paper
• Secondary Intracerebral Hemorrhage Due to Early Initiation of Oral Anticoagulation After Ischemic Stroke: An Experimental Study in Mice

  2012cites this paper
• reducing thrombosis, blood-brain-barrier damage and inflammation Kininogen deficiency protects from ischemic neurodegeneration in mice by

  2012cites this paper
• Kininogen deficiency protects from ischemic neurodegeneration in mice by reducing thrombosis, blood-brain barrier damage, and inflammation.

  2012cites this paper
• Inhibition of Factor XII-Mediated Activation of Factor XI Provides Protection Against Experimental Acute Ischemic Stroke in Mice

  2012cites this paper
• No Influence of Dabigatran Anticoagulation on Hemorrhagic Transformation in an Experimental Model of Ischemic Stroke

  2012influential citation
• Thrombolytic therapy for ischaemic stroke in patients using warfarin: a systematic review and meta-analysis

  2012cites this paper
• Thrombolysis with recombinant tissue plasminogen activator under dabigatran anticoagulation in experimental stroke

  2012cites this paper
• Akuter ischämischer Schlaganfall

  2011cites this paper
• Warfarin Anticoagulation Exacerbates the Risk of Hemorrhagic Transformation after rt-PA Treatment in Experimental Stroke: Therapeutic Potential of PCC

  2011cites this paper
• Rapid Reversal of Anticoagulation Prevents Excessive Secondary Hemorrhage After Thrombolysis in a Thromboembolic Model in Rats

  2011cites this paper
• Trasformazione emorragica dello stroke ischemico e trattamento della trasformazione emorragica durante terapia trombolitica

  2011cites this paper
• Appendix E ECOTOX Open Literature Bibliography

  2010cites this paper